Yesterday, we started our participation in #IAS2019, with a dialogue between indigenous organizations & #HIV expert… twitter.com/i/web/status/1…

RT @IAS_conference: Starting now! Monday's Plenary Session in Sala A with @WitsRHI's Gloria Maimela, @USC's Paula Cannon, and @CallenLorde'…

RT @IAS_conference: "Despite the successful scale up of ART in #LatinAmerica, AIDS-related mortality has barely changed in the last 20 year…

RT @IAS_conference: "Close to two thirds of all people living with #HIV in 2018 were receiving lifesaving antiretroviral therapy… Six cou…

RT @IAS_conference: That's a wrap on the #IAS2019 Opening Session. On behalf of everyone at the International AIDS Society, we'd like to of…

⚠️TUNE IN TOMORROW⚠️
Don´t miss the launch of the 💻 Virtual course on the implementation of HEARTS ❤️ Technical Pac… twitter.com/i/web/status/1…

RT @WHO: Clinical trials of antiretrovirals (ARVs) began in 1985 – the same year that the first #HIV test was approved – and the first ARV…

RT @WHO: Generic manufacturing of antiretrovirals would only start in 2001 providing bulk, low-cost access to ARVs for highly affected coun…

RT @WHO: In 1996, @UNAIDS was established to lead a multisectoral response: to tackle marginalization, stigma and discrimination, to addres…

RT @WHO: In 2000, the @UN General Assembly adopted the Millennium Development Goals, which committed to ‘halting and reversing the #AIDS ep…